Alumis (ALMS) Change in Acquisitions & Divestments (2023 - 2025)
Alumis (ALMS) posted quarterly Change in Acquisitions & Divestments of $142.5 million for Q4 2025, up 65.73% year-over-year from $86.0 million in Q4 2024, and down 11.55% quarter-over-quarter from $161.1 million in Q3 2025.
Analysis
Alumis (ALMS) Change in Acquisitions & Divestments (2023 - 2025) Analysis & Trends
Alumis (ALMS) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $142.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Acquisitions & Divestments rose 65.73% year-over-year to $142.5 million; the TTM figure through Dec 2025 stood at $448.0 million (up 249.96% YoY), while the FY2025 annual figure was $448.0 million, up 249.96% from the prior year.
- Change in Acquisitions & Divestments fell to $142.5 million in Q4 2025 per ALMS's latest filing, from $161.1 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $161.1 million in Q3 2025 and bottomed at $1.0 million in Q1 2024.
- Historically, Change in Acquisitions & Divestments has averaged $65.1 million across 3 years, with a median of $64.0 million in 2025.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 6300.0% in 2025 and fell as far as 65.73% in 2025.
- Alumis' Change in Acquisitions & Divestments stood at $9.8 million in 2023, then soared by 782.05% to $86.0 million in 2024, then surged by 65.73% to $142.5 million in 2025.
- Business Quant data shows ALMS's Change in Acquisitions & Divestments at $142.5 million in Q4 2025, $161.1 million in Q3 2025, and $80.3 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Alumis | 1.43 Bn | 923.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 142.53 Mn |
| Sep 30, 2025 | 161.15 Mn |
| Jun 30, 2025 | 80.27 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 86.00 Mn |
| Sep 30, 2024 | 34.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Sep 30, 2023 | 9.75 Mn |